Pre-referral rectal artesunate in severe malaria: flawed trial

Area of Science:

• Clinical Trials Methodology
• Infectious Diseases
• Public Health

Background:

• Severe malaria requires immediate treatment, crucial in remote areas lacking timely access to healthcare.
• A 2009 trial evaluated pre-referral rectal artesunate to prevent severe malaria progression during patient transit.
• The World Health Organization (WHO) recommends rectal artesunate based on this trial's findings.

Purpose of the Study:

• To conduct a detailed evaluation of the design, conduct, analysis, reporting, and practical aspects of the 2009 rectal artesunate trial.
• To assess the scientific quality of the trial for potential inclusion in a systematic review.
• To identify deficiencies that may impact the reliability and applicability of the trial's conclusions.

Main Methods:

• A checklist-based and in-depth evaluation of the trial was performed.
• Evaluation criteria were based on the CONSORT statement, clinical trial methodology literature, and malaria research practices.
• Specific attention was given to trial design, participant enrollment, data collection, outcome analysis, and reporting.

Main Results:

• The trial exhibited significant deficiencies, including unstated inclusion/exclusion criteria, enrollment of ineligible subjects, and inadequate recruiter training.
• Excessive heterogeneity between centers, undefined outcome schedules, data gaps, inconsistent endpoint utilization, and flawed statistical analyses were noted.
• Concerns regarding patient welfare and compromised external validity due to data exclusion were raised; reanalysis did not support the original conclusions.

Conclusions:

• The trial is characterized by numerous serious deficiencies in design, implementation, and data analysis.
• Interpretation and reporting of findings are inadequate, rendering the applicability of results unclear.
• The study's flaws raise significant doubts about its conclusions and highlight areas for improvement in trial conduct and patient welfare.